FDA REQUIRES BLACK BOX WARNING ON LEVAQUIN LABEL
FDA notified makers of fluoroquinolone antimicrobial drugs, including Levaquin, for systemic use of the need to add a boxed warning to the prescribing information about the increased risk of developing tendinitis and tendon rupture in patients taking fluoroquinolones and to develop a Medication Guide for patients.
LEVAQUIN & TENDON RUPTURE
Fluoroquinolones, including Levaquin, are associated with an increased risk of tendinitis and tendon rupture. This risk is further increased in those over age 60, in kidney, heart, and lung transplant recipients, and with use of concomitant steroid therapy.
SIGNS OF A LEVAQUIN INJURY
FDA stated that physicians should advise patients, at the first sign of tendon pain, swelling, or inflammation, to stop taking the Levaquin, to avoid exercise and use of the affected area, and to promptly contact their doctor.
THE LEVENSTEN LAW FIRM CAN HELP PROTECT YOUR RIGHTS
If you or a family member took Levaquin and suffer from a tendon rupture or tendinitis. We urge you to contact our office to obtain additional information about recovering financial compensation
